Options
The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries - PURE: a cohort study
Journal
The Lancet Global Health
ISSN
2214-109X
Date Issued
2025-08
Author(s)
Darryl P Leong
Rita Yusuf
Romaina Iqbal
Alvaro Avezum
Afzalhussein Yusufali
Annika Rosengren
Jephat Chifamba
Fernando Lanas
Maria Luz Diaz
J Jaime Miranda
Kairat Davletov
Erkin Mirrakhimov
Karen Yeates
Rasha Khatib
Khalid F Alhabib
Sadi Gulec
Maria José Paucar
Jose Patricio Lopez-Lopez
Viswanathan Mohan
Rajeev Gupta
Biju Soman
P V M Lakshmi
Paul Poirier
Koon Teo
Katarzyna Zatonska
Nafiza Mat-Nasir
Galina Artamonova
Bo Hu
Zhiguang Liu
Xiaoyun Liu
Antonio Dans
Sumathy Rangarajan
Salim Yusuf
Maria Luz Diaz
Agustina Galatte
Mauricio Salvador
Maria Soledad Herrera
Sabrina Bellotti
Silvana Di Benedetti
Silvia Bérgamo
Mohammad O Rahman
Rita Yusuf
Syed AKS Ahmed
Afreen Z Khan
Nazratun Nayeem
Mira Mitra
Shahidul Islam
Fuad Pasha
Alvaro Avezum Junior
Precil Diego Miranda Neves
Rafael Amorim Belo Nunes
Larissa Oliveira Santos
Lidiane Fatima Assis Silva
Thais Paula Pio
Claudia Malerba
Scott Lear
Meghan MacLeod
Erica Corber
Veronica de Jong
Ina Vukmirovich
Danijela Gasevic
Vaven Ghag
Azlan Nur Saidy
Rochelle Nocos
Jasmine Lim
Karen Suarez
Brianna Nasrallah
Hassan Mir
Andreas Wielgosz
Paul Poirier
Marie-Eve Piché
Tomas Cieza
Ginette Turbide
Myriam Pettigrew
Anne-Sophie Bourlaud
Sumathy Rangarajan
Koon Teo
Sonia Anand
Clara Chow
Martin O'Donnell
Erica Smith
Andrew Mente
Darryl Leong
Andrew Smyth
Philip Joseph
MyLinh Duong
Aditya Khetan
Harry Klimis
Russell D'Souza
Victoria Miller
Marjan Walli-Attaei
Shofiqul Islam
Chinthanie Ramasundarahettige
Shrikant Bangdiwala
Kumar Balasubramanian
Gloria Wong
Nishitha Jeyachandradhas
Xiumei Yang
Cissy Tang
Leslie Farago
Martin Zarate
Jerad Godreault
Mark Haskins
Mahesh Jethva
Dat Nguyen-Quang
Andrew Pineau
Gianluca Rigitano
Ashish Vaghela
Mahshid Dehghan
Alannah Aliberti
Ayah Zaki
Dawn Agapay
Karan Chrysler
David Krol
Fathimath Shifaly
Jacqueline Rimac
Monica Jakymyshyn
Maha Mushtaha
Nazar Kandy
Roxanna Solano
Sudha Gopal
Shameena Ramacham
Nobu Shimizu
Tina Tongana
Fernando T Lanas
Pamela J Serón
María J Oliveros
Jéssica I Hidalgo
Yasmín G Palacios
Benjamín E Ruiz
Camilo A Acosta
Lisheng Liu
Wei Li
Bo Hu
Lu Yin
Jun Zhu
Yan Liang
Yi Sun
Yang Wang
Qing Deng
Xingyu Wang
Xiaoru Cheng
Chuangshi Wang
Sidong Li
Weida Liu
Xinyue Lang
Zhiguang Liu
Shelly LA Tse
Guoliang Han
Fanghong Lu
Yan Hou
Xiaoyang Liao
Di Chen
Peng Zhang
Ning Li
Rensheng Lei
Minfan Fu
Yu Liu
Xiaojie Xing
Youzhu Yang
Quanyong Xiang
Jinhua Tang
Zhengrong Liu
Deren Qiang
Aiying Han
Jinkui Yang
Xinbin Wu
Chunmei Liu
Guomin He
Qian Zhao
Aobulikasimu Resalaiti
Hui Wang
Yahong Zhi
Yali Wang
Yuanting Ma
Haibing Ma
Lihua Hu
Li Zhang
Guoqing Liu
Junying Wang
Hui Jin
Kai You
Tao Peng
Jing Su
Yingxin Zhao
Patricio Lopez-Jaramillo
Maritza Perez-Mayorga
Johanna Otero-Wandurraga
Paul Anthony Camacho
Carlos Cure-Cure
Miguel Urina-Triana
Alfonso Campo
Edgar Arcos
Claudia Narvaez
Aristides Sotomayor
Doris Gomez
Henry Garcia
Manuel Urina-Triana
Gregorio Sanchez-Vallejo,
Jose Patricio Lopez-Lopez
Maria Angelica Muñoz
Olga Lucia Bello
Tatiana Vasquez
Monica Niño
Shislem Rodriguez
Maria Camila Campo
Mavel Lopez-Flecher
Michelle Vega
Katherine J. Granda
Prem K. Mony
Mario Vaz
Sumathi Swaminathan
Ankalmadagu V. Bharathi
Kiruba Sankar
Anura V. Kurpad
Krishnaswamy G. Jayachitra
Nitesh Kumar
Raju Anthony
Karamala Murali
Chengi Balaji
Krishnappa Amaranadh
Ponnuswamy Vijayalakshmi
Sirana Sandhya
Jennifer Jayaprakash D
Nalini Sharin Toppo
Naveen Jagadeeshan
Parvathi Narayanappa
Pooja H Telagavi
Viswanathan Mohan
Ranjit Mohan Anjana
Mohan Deepa
Kumar Parthiban
Lakshmanan Dhanasekaran
Sundaram Sureshkumar
Manivel Nandhakumar
Doss Kalaivani
Elumalai Karthick
Kakade Vivek
Santhappan Vijaybaskar
Rajeev Gupta
Lalit Mohan Sharma
Indu Mohan
Rooma Bhargava
Madhusudan Sharma
Devendra Sharma
Raman Kutty Velappallil
Vijayakumar Krishnapillai
Sanjeev Nair
Kamala Rammohan
Manu Muraleedharan Sarojini
Thomas Iype
Veena Ambily
Arunlal Anitha Rajappan Nair
Divya Santhakumari
Jith Sreerangan
Sucharitha Kamalam
Rajesh Kumar
Pinnaka Venkata Maha Lakshmi
Manmeet Kaur
Vivek Sagar
Ritin Mohindra
Rupali Mahajan
Kamaldev Sharma
Rupinder Singh
Pinki Bhatt
Jyoti Maurya
Babita Chauhan
Kamaldeep Singh
Roya Kelishadi
Noushin Mohammadifard
Ahmad Bahonar
Kairat Davletov
Batyrbek Assembekov
Muktar Kulimbet
Erkin Mirrakhimov
Saamay Abilova
Erkaiym Bektasheva
Yrysbek Mamat uulu
Malik Nabiev
Rano Arapova
Umid Zakirov
Azamat Asanbaev
Nursultan Asanaliev
Nafiza Mat-Nasir
Kean Kiet Ng
Tengku Saifuddin Tengku Ismail
Anis Safura Ramli
Norashikin Mohamed Noor Khan
Mazapuspavina Md Yasin
Farnaza Ariffin
Maizatullifah Miskan
Suraya Abdul-Razak
Nik Munirah Nik Mohd-Nasir
Noorhida Baharudin
Mohamed Syarif Mohamed-Yassin
Hasidah Abdul-Hamid
Razif Dasiman
Boon Peng Hoh
Fadhlina Ab Majid
Najmin Abu Bakar
Rasyidah Salleh
Mardhiah Baharom
Siti Radziah Norlizan
Noor Azziana Ismail
Sarina Ali
Che Wan Juliana Che Wan Jaafar
Azmi Mohd Tamil
ZALEHA MD ISA
ROSNAH ISMAIL
Noraidah Saian
Nurul Hafiza Ab Razak
siti norzulaikha rahim
Khairul Hazdi Yusof
FARAH ADILLA FAUZI
Nur Nadia Mohamed
FATIN AZIERAH FAUZI
nurul afifah jusoh
Mohd Hasni Jaafar
Noorhassim ISMAIL
Khawar Kazmi
Rehman Khawaja
Shehzad Ali
Muhammad Asim
Mohan Jumma
Sana Bachal
Nighat Almas
Safa Noreen
Umaiyeh Khammash
Rasha Khatib
Rita Giacaman
Lia Aileen M. Palileo - Villanueva
Antonio L. Dans
Marc Evans M. Abat
Chareece Mae T. Zamora - Pudol
Louie P. Pudol
Sheila Lyn P. Pudol
Diana Rose B. Tubig
Kristine Joy C. Tenorio
Charlene C. Abaquin
Mary Stephanie M. Malayang
Jorissa A. Bordeos
Keenah S. Salvador
Paola Kristina S. Genosas
Clifford D. Villas
Nikki Fe Dominique C. Guerero
Angelica N. Dorilla
Genoveva B. Nethercott
Dante D. Morales
Jose Donato A. Magno
Lauren Kay M. Evangelista
Lauro L. Abrahan IV
Daniel Francisco T. Morales
Katarzyna Zatońska
Andrzej Szuba
Alicja Basiak-Rasała
Katarzyna Połtyn-Zaradna
Tomasz Zatoński
Maria Wołyniec
Dorota Różańska
Bożena Regulska-Ilow
Rafał Ilow
Marta Manczuk
Pawel Macek
Olga L. Barbarash
Galina V. Artamonova
Elena V. Indukaeva
Evgeny D. Bazdyrev
Daria P. Tsygankova
Olga V. Nachratova
Alyena S. Agienko
Khalid F Alhabib
Mostafa Alshamiri
Hani Altaradi
Monzir Abdulrahman
Rehab Nouri
Lanthe Kruger
Cristian Ricci
Andries F van Oort
Sarah J Moss
Marlien Pieters
Herculina S Kruger
Elizabeth Catherina (Rina) Swart
Thandi Puoane
Nasheeta Peer
Andre Kengne
Estelle Victoria (Vicky) Lambert
Naomi (Dinky) Levitt
Nelia Steyn
Lungiswa Tsholekile
Juley de Smidt
Lloyd Leach
Ehimario Igumbor
Bonaventure Egbujie
Annika Rosengren
Marie Andreasson
Annica Gustavsson
Jeanette Kembro Johansson
Ing-Marie Jonsson Lindgren
Ida Segerqvist
Lisel Wirdeman
Ann-Louise Hummelblad
Bruno F. Sunguya
Karen E. Yeates
Nicola J. West
Aytekin Oguz
Sadi Gulec
Ahmet Temizhan
Kubilay Karsidag
Yuksel Altuntas
Nese Imeryuz
Mirac Vural Keskinler
K. Burcu Tumerdem Calik
Ozge Telci Caklili
A. Arzu Akalin
Mustafa Kilickap
Afzalhussein M Yusufali
Hamda H Khansaheb
Madiha H S Abdelmotagali
Alawi Alsheikh-Ali
Tom Loney
Marwan Zidan
Douaa F Youssef
Olfat Z S Ahmad
Eman F El-Sayed
Mai H Awadalla
Suad H Ahmed
Jephat Chifamba
Tatenda L Ncube
Brian J Ncube
Tavengwa G Manenji
Nyasha G Chigariro
Abstract
Background: Current strategies to prevent adverse cardiovascular outcomes focus primary prevention in high-risk groups and secondary prevention in people with known cardiovascular disease. We aimed to determine the proportion of events occurring in lower-risk groups globally.
Methods: We included people aged 40 years to younger than 75 years who were enrolled in the Prospective Urban Rural Epidemiology (PURE) study, which is an ongoing, international, prospective, population-based cohort study that started recruiting adults from households selected to be broadly representative of the sociodemographic composition of their communities. We prospectively documented fatal or non-fatal myocardial infarction, stroke, heart failure, or any other fatal cardiovascular event stratified by history of cardiovascular disease and by the 10-year predicted disease risk scores based on WHO 2019 laboratory risk tables (<10% [low], 10% to <20% [intermediate], and ≥20% [high]) in people without previous cardiovascular disease from 26 high-income, middle-income, and low-income countries. Outcome event rates were standardised for the cohort's age and sex distribution.
Findings: Between July 11, 2000, and May 6, 2019, 128 973 participants were included from 26 countries (mean age 53·6 years [SD 8·2]; 75 858 [58·8%] were female and 53 115 [41·2%] were male). We observed 11 483 outcome events affecting 8·9% of the cohort during a median follow-up of 12·3 years (IQR 9·8–14·6). Among participants, 89 508 (69·4%) had a low cardiovascular disease risk, 22 363 (17·3%) had an intermediate cardiovascular disease risk, and 5529 (4·3%) had a high cardiovascular disease risk, while 11 573 (9·0%) had known cardiovascular disease. The age-standardised and sex-standardised cardiovascular disease incidence rates per 1000 person-years was 4·1 (95% CI 4·0–4·2) in the low-risk group, 17·7 (15·2–20·2) in the intermediate-risk group, and 40·8 (25·1–56·4) in the high-risk group. Overall, 41% of outcome events occurred in cardiovascular disease-naive participants at low risk. The proportion of adverse cardiovascular outcomes occurring in this low-risk group was inversely related to country income level (32% in high-income, 38% in middle-income, and 54% in low-income countries) and was higher in women (51%) than in men (32%). Interpretation: To achieve a substantial population-level reduction in cardiovascular disease, a fundamental change is needed, so that preventive strategies for cardiovascular disease extend beyond those at high or even intermediate predicted risk to include those at considered to be at low risk.
Funding: The funding bodies are listed in the appendix (p 29).
Methods: We included people aged 40 years to younger than 75 years who were enrolled in the Prospective Urban Rural Epidemiology (PURE) study, which is an ongoing, international, prospective, population-based cohort study that started recruiting adults from households selected to be broadly representative of the sociodemographic composition of their communities. We prospectively documented fatal or non-fatal myocardial infarction, stroke, heart failure, or any other fatal cardiovascular event stratified by history of cardiovascular disease and by the 10-year predicted disease risk scores based on WHO 2019 laboratory risk tables (<10% [low], 10% to <20% [intermediate], and ≥20% [high]) in people without previous cardiovascular disease from 26 high-income, middle-income, and low-income countries. Outcome event rates were standardised for the cohort's age and sex distribution.
Findings: Between July 11, 2000, and May 6, 2019, 128 973 participants were included from 26 countries (mean age 53·6 years [SD 8·2]; 75 858 [58·8%] were female and 53 115 [41·2%] were male). We observed 11 483 outcome events affecting 8·9% of the cohort during a median follow-up of 12·3 years (IQR 9·8–14·6). Among participants, 89 508 (69·4%) had a low cardiovascular disease risk, 22 363 (17·3%) had an intermediate cardiovascular disease risk, and 5529 (4·3%) had a high cardiovascular disease risk, while 11 573 (9·0%) had known cardiovascular disease. The age-standardised and sex-standardised cardiovascular disease incidence rates per 1000 person-years was 4·1 (95% CI 4·0–4·2) in the low-risk group, 17·7 (15·2–20·2) in the intermediate-risk group, and 40·8 (25·1–56·4) in the high-risk group. Overall, 41% of outcome events occurred in cardiovascular disease-naive participants at low risk. The proportion of adverse cardiovascular outcomes occurring in this low-risk group was inversely related to country income level (32% in high-income, 38% in middle-income, and 54% in low-income countries) and was higher in women (51%) than in men (32%). Interpretation: To achieve a substantial population-level reduction in cardiovascular disease, a fundamental change is needed, so that preventive strategies for cardiovascular disease extend beyond those at high or even intermediate predicted risk to include those at considered to be at low risk.
Funding: The funding bodies are listed in the appendix (p 29).